Geoffrey Purtill - Apr 24, 2023 Form 4 Insider Report for INVACARE CORP (IVC)

Role
President and CEO
Signature
/s/ Geoffrey Purtill, by Kristofer K. Spreen, his attorney-in-fact, pursuant to Power of Attorney dated November 24, 2021, on file with the Commission
Stock symbol
IVC
Transactions as of
Apr 24, 2023
Transactions value $
$0
Form type
4
Date filed
4/24/2023, 05:45 PM
Previous filing
Feb 28, 2023
Next filing
May 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IVC Common Shares Disposed to Issuer $0 -128K -82.19% $0.00 27.8K Apr 24, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IVC Employee Stock Option (Right to Buy) 17.6K Apr 24, 2023 Common Shares 17.6K Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person forfeited 128,293 restricted stock units back to the issuer.
F2 No transaction is being reported on this line. Reported on previously filed Form 3.
F3 The reporting person holds previously reported options to buy 17,611 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. All options were granted on March 16, 2017, at an exercise price of $12.15 per share, will expire on March 16, 2027, and became exercisable on December 31, 2019.
F4 The current balance reflects the expiration of 5,000 options on March 18, 2023.